MedTrace Logo

Dermal Regeneration Photosynthetic Matrix

NCT03960164 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-11-21

No results posted yet for this study

Summary

The aim of the study is to demonstrate that dermal regeneration photosynthetic matrix applied in patients with acute clean skin wound is safe.

Conditions

  • Skin Wound

Interventions

COMBINATION_PRODUCT

Dermal regeneration photosynthetic matrix (DRPM)

Primary Procedure: DRPM implantation 1. Wound bed preparation and cleaning. 2. DRPM implantation. 3. Illumination with LED device. Secondary Procedure: Autologous partial skin graft

Sponsors & Collaborators

  • Hospital del Salvador

    collaborator OTHER

  • SymbiOx Inc.

    collaborator UNKNOWN

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Tomas Egaña, PhD. · Pontificia Universidad Catolica de Chile

  • Antonio Eblen-Zajjur, MD., PhD. · Pontificia Universidad Catolica de Chile

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2023-06-30
Completion
2023-11-01

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03960164 on ClinicalTrials.gov